Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by boazklinghornon Jun 05, 2023 11:27am
198 Views
Post# 35480433

The reality

The reality As we head into the AGM it is becoming clear that 1H 2022 was an outlier for revenue. The last three quarters have us at an annual revenue run rate under 16MM. As we only have the one customer CZO is a price taker not a price maker. There are currently zero levers managment can use to increase sales. Whatever Symrise orders is the extent of our sales. This is not a great way to run a company. Despite Gilles endless promises to "transition" the company, after his entire career CZO is still the same contrat manufacturer it has always been.
It bears repeating that even if shareholders send a strong maessage and remove Gilles and maybe others from the board he will still be our CEO but notice will have been given that shareholders demand results as we absolutley should, and that we are prepared to protect our interests in the face of dismissve entltled entrenched managment.
Remember this is the only time you will ever get to confront this group if we fail ro send a strong maessage here they will go dark for another year. The only message they will hear is removal. Gilles only got 66% last year and others were under 60. This changed nothing about how the run the company and more importamtly how they treat the owners of the company. 
Shout out to Littlefinger for the great insights. Keep it up. 
<< Previous
Bullboard Posts
Next >>